Trametinib + Doxorubicin + CISPLATIN + Gefitinib + Disulfiram + SUNITINIB + Methotrexate

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Trametinib + Doxorubicin + CISPLATIN + Gefitinib + Disulfiram + SUNITINIB + Methotrexate
Treatment and conditionWhere it standsTrials
Trametinib + Doxorubicin + CISPLATIN + Gefitinib + Disulfiram + SUNITINIB + Methotrexate for neoplasm metastasisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Trametinib + Doxorubicin + CISPLATIN + Gefitinib + Disulfiram + SUNITINIB + Methotrexate for osteosarcomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1